May 2024

UROLOGY

USING GENOMICS FOR ACTIVE SURVEILLANCE

​Featuring: Ashley E. Ross, MD, PhD

Episode Summary

Ashley E. Ross, MD, PhD, joined Aditya Bagrodia, MD, on BackTable Urology to discuss risk factors for prostate cancer and the importance of genome expression tests to predict tumor characteristics.
 
Dr. Ross and Dr. Bagrodia discuss:
  • The significant role of Gleason grade groups
  • Genetic variants and genetic predisposition for prostate cancer
  • The importance of evaluation beyond the microscopic cellular structure of the cancer
  • Using tools like MRI to reduce unnecessary biopsies
  • Factors involved in deciding to treat or observe prostate cancer
  • The three possible lines of progression that prostate cancer can take and how to identify them
  • The differences between germline and genomic testing
 
Dr. Ross and Dr. Bagrodia also highlight the critical role of shared decision-making, discussing the cost of genomics and helping patients know what to expect.
 
Listen to the podcast episode >
Ashley E. Ross, MD, PhD, Associate Professor of Urology at Northwestern Medicine
​

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like